tirzepatide compound availability dosage chart for weight loss 1 and GIP therapy Compounded Tirzepatide Program: Results, Timeline

The 122 patent is set to expire in March 2026, marking 20 years from its filing date

Not PBS-funded with a GLP-1 RA

In many cases, providers apply criteria similar to those used for Wegovy (another semaglutide medication FDA-approved for weight management)

Related products Easy Glow Gold Strong Gluta-C Body Milk 0 out of 5 Easy Glow Strong Half Cast Body Milk Lotion 0 out of 5 Extreme White Intense Toning Day SPF30 & Night Cream 0 out of 5 Gluta+Kojic Extra Fort Concentrate Serum with Fruit Acids 0 out of 5 Huile Bio Traitante 42 Heures Juste Lightening 0 out of 5 Make Me White 7 Days Action Day & Night Face Cream 0 out of 5 Mercy Ointment 0 out of 5 Supreme White Carrot Active Intense Beauty Milk 0 out of 5

Shop Complete Routine GHK-Cu scalp serum for scalp care, fuller hair, stronger hair support and targeted daily growth routines

WEEKLY MONITORING We track your progress and adjust as needed